Randomized Study of Bevacizumab vs Ranibizumab for Age-Related Macular Degeneration: Inappropriate Conclusions
Subramanian and associates report that their randomized controlled trial originally was powered on the basis of an overall sample size of 135 patients (90 in the bevacizumab group and 45…